FDA
FDA proposes adding ‘race and ethnicity’ category to expanded access requests – Endpoints News
Endpts
FDA OCE commentary: Cancer burden facing Asian Americans partly caused by racism
Cancer Letter
FDA Guidance on Diversity Plans in Clinical Trials: What You Need to Know | Bass, Berry & Sims PLC
JD Supra
FDA issues ambitious new draft guidance to promote clinical trial diversity | Hogan Lovells
JD Supra
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
